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Evaluating “payback” on biomedical research
Biomedical funding decisions should be
audited
Editor—Grant et al note that organisations
that fund biomedical research assume that
the research they support will lead to an
eventual improvement in health.1 Because
clinical guidelines represent one of the final
links between basic research and actions to
improve health, they looked at which studies
were cited in guidelines.
Although their analysis is a valuable
move away from the naive use and abuse of
citation counts and impact factors, they may
have attempted to bridge too great a
distance in assessing which publications in
the serial peer reviewed literature were cited
in guidelines. Guidelines should be based on
systematic reviews of all the studies relevant
to particular clinical questions. They should
not be based on the biased subsets of reports
of primary research included in biblio›
graphic databases or those that are suffi›
ciently concise to be published in serial
journals.2
It would be helpful if Grant et al would
indicate the extent to which references to
systematic reviews were cited in the guide›
lines they studied. The “payback” from
primary studies might then be studied by
assessing their contribution to these system›
atic reviews. For example, was a primary
study judged to be of sufficiently high quality
to have been included in a systematic review
at all? If so, what contribution did it make to
the totality of the relevant evidence?
Grant et al suggest that an alternative to
the retrospective approach that they used
for assessing payback would be “to identify a
body of basic research published some time
ago and follow its subsequent knowledge
flow.” A more informative approach would
be to identify a body of basic research
funded some time ago. Payback could
then be assessed not only in terms of
whether it led to an eventual improvement
in health but also whether it was completed
and published.
Failed research and failure to publish
successful research are costs to the public.
Yet I am not aware of any public or charit›
able organisation that funds biomedical
research that routinely publishes audits of its
investment decisions using criteria such as
these.
Iain Chalmers director
UK Cochrane Centre, NHS Research and
Development Programme, Oxford OX2 7LG
ichalmers@cochrane.co.uk
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Authors’ reply
Editor—Chalmers asks what proportion of
references cited in the guidelines we studied
were systematic reviews. The answer is
68/2501 (2.7%). We made this calculation by
using the keywords “systematic” (for system›
atic review) and “meta” (for meta›analysis) in
the title of the publication. Interestingly,
there was no difference between publica›
tions in peer reviewed journals (56/2043;
2.7%) and the so called grey literature
(12/458; 2.6%). Although Chalmers argues
that clinical guidelines should be based on
systematic reviews of the literature, these
data show that authors of guidelines are cit›
ing the primary research.
The Cochrane Database of Systematic
Reviews could provide a useful resource in
undertaking applied bibliometric studies.
Chalmers notes that the prospective tracing
of funded research, as opposed to that only
published, may be more informative in
auditing the outcomes of public or charit›
able funding of biomedical research. We
agree.
Jonathan Grant policy adviser
j.grant@wellcome.ac.uk
Robert Cottrell policy officer
Gail Fawcett policy officer
Policy Unit, Wellcome Trust, London NW1 2BE
Françoise Cluzeau lecturer in health services
Health Care Evaluation Unit, St George’s Hospital
Medical School, London SW17 0RE
Pragmatic approach is effective
in evidence based health care
Editor—We agree with Guyatt et al that
providing evidence based answers to clinical
questions requires intensive study and appli›
cation if the process is seen in the context of
a systematic review of the original literature.1
The main stumbling block remains the diffi›
culty of constructing complex searches
appropriate for a range of potential sources.
We suggest that many typical clinical
questions can be answered by using a limited
range of extracting, evaluating databases,
which can be interrogated with simple two
step or three step search formulations. Typi›
cally these sources contain several thousand
references, as opposed to several millions
on large databases such as Medline or
EMBASE with their unfavourable signal to
noise ratio.
The three sources that in our experience
have a high yield of material related to
evidence based health care are the clinical
queries option in PubMed2; the Cochrane
Library with its four sections (systematic
reviews, the CRD (Centre for Reviews and
Dissemination) database of reviews of effec›
tiveness, the register of controlled trials, and
the NHS economic evaluation database)3;
and the TRIP (turning research into
practice) database from the Centre for
Research Support, Cardiff.4
These three databases typically retrieve
fewer than 10 references provided that two
or at most three relevant and discriminating
terms are selected for a simple search. We
often suggest to trainees that they should
formulate their searches as if they were
sending a telegram: which two or three
words would you transmit to a colleague to
ensure that he or she can imagine the clini›
cal question? Thus the question “How
efficient is a single dose of a steroid for out›
patient croup?” suggests the search “croup
and outpatient,” which identifies small sets
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( < 10) containing a target reference5 on any
of the three databases mentioned above.
This pragmatic approach, although no
substitute for systematic reviews for those
undertaking more extensive searches, is
influenced by William of Occam’s principle
of “if in doubt keep it simple” and is a valid
option for busy clinicians.
John Clarke librarian
Reinhard Wentz trial search coordinator, Cochrane
Injuries Group
r.wentz@ich.ucl.ac.uk
Institute of Child Health, London WC1N 1EH
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Evidence should be accessible
as well as relevant
Editor—National policy on research and
development encourages the delivery of
health care that is of proved efficacy and
based on research.1 Barker and Gilbert say
that evidence of clinical effectiveness has to
be relevant to health professionals for it to
be incorporated into clinical practice.2 We
conducted a survey of community nurses
and community based professionals allied to
medicine (PAMs) employed by one east
London community trust to identify the
areas of their work where they see evidence
as important.
We adapted a postal questionnaire
survey that we used in 1997 among general
practitioners and practice staff in teaching
practices.3 In all, 124 completed question›
naires were returned (51%). Respondents
were asked for their views on the role of evi›
dence and the sources of evidence that they
accessed and were also asked to list up to
three areas where research evidence would
be relevant to their work.
Eighty one per cent of the respondents
showed a positive attitude to the use of
research evidence in the daily management
of patients and clients and in the planning of
services. This compares with 90% of general
practitioners in the 1997 survey. There were
differences between these two groups in the
sources of evidence that were accessed
(table).
Colleagues were used as a source of evi›
dence by a similar proportion in each group,
but community nurses and PAMs were less
likely to consult experts or journals. Nor did
these professionals access the internet for
evidence: 64% (77/121) reported never hav›
ing used the internet for any purpose. Com›
puter projects such as PRODIGY are
bringing evidence based decision making
into clinical settings.4 However, half of our
respondents (58/117) reported having no
access to a clinical computer system.
Community nurses and PAMs are inter›
ested in having access to evidence that is rel›
evant to their work, especially in areas such
as community mental health interventions,
appropriate timing of developmental checks
in children, prevention of falls among
elderly people, pain management, interven›
tion of health visitors in postnatal depres›
sion, foot and leg ulcer care, and music and
art therapy. Training courses in evidence
based health care need to consider the effec›
tiveness of interventions in these areas. We
agree with Barker and Gilbert that the
impact of evidence based health care
depends on its relevance to the work of
practitioners in the field, but practitioners
also need access to such evidence.
M Falshaw research coordinator
m.falshaw@qmw.ac.uk
Y H Carter professor
R W Gray research assistant
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Costs are as important as
outcomes
Editor—History provides the framework
within which meaning is generated in any
system, and the issue of the BMJ focusing on
doctors and nurses in the NHS (15 April)
showed the complex interplay of stakehold›
ers and their motives. Against a background
of increasing demands on limited resources,
however, decisions about the doctor›nurse
skill mix should be made on the basis of cost
effectiveness, not historical precedent.1 To
facilitate this process, Venning et al showed
that there were no differences in outcomes
whether nurses or general practitioners pro›
vided care in minor illness and that health
service costs were similar.2
The perspective of a study defines which
costs to count. For questions that have impli›
cations for long term skill mix, all NHS costs
should be considered irrespective of who
bears them. For example, the estimated cost
of training annuitised over the expected
working life is £4735 a year for a nurse and
£21 215 a year for a doctor.3 Including these
values will alter this study’s conclusion and
show that nurses are more cost effective than
general practitioners for the treatment of
minor illness.
The important lesson is that when inter›
preting studies that influence health service
delivery, researchers and decision makers
must not focus on a comprehensive
measurement of outcomes at the expense of
an inadequate consideration of costs.
D P Kernick general practitioner
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Breast cancer screening
Screening has to be combined with good
surgical and oncological services
Editor—Dickinson in her editorial stated
that there are serious doubts about the con›
tribution of breast screening to a fall in
breast cancer deaths.1 This statement is
based on the controversial article by
Gotzsche and Olsen,2 which at the time of its
publication attracted much media attention.
The repetition of this allegation without a
more balanced view is erroneous, seems to
support the findings of this article unequivo›
cally, and has the potential to undermine
confidence in the breast screening pro›
gramme.
The article by Gotzsche and Olsen was
based on a meta›analysis of eight ran›
domised trials of breast screening including
half a million women. Because of the
randomisation process and using age as a
marker of imbalance, Gotzsche and Olsen
believed that only the trials from Malmö and
Canada were methodically correct, and
because these two trials failed to show a sur›
vival advantage in the screened group, they
concluded that breast screening was not jus›
tifiable. The article can be criticised on
several points including its own methods,3
the inclusion of the Canadian trial, which
was a combined mammogram and physical
examination compared with physical exam›
ination and should therefore not have been
included in an analysis of trials of mammog›
raphy alone, and the exclusion of the most
recent data from the Malmö trial, which had
shown a relative risk of death from breast
cancer of 0.81 and a 26% reduction in breast
cancer mortality. The study is also at odds
with other meta›analyses such as that by
Wald et al, which showed a 24% lower mor›
tality related to breast cancer in women aged
over 50 years invited for mammography.4
Sources of evidence accessed at least weekly. Values are percentages (numbers)
Source
Community nurses and community based PAMs
(n=119) General practitioners (n=129)
Colleagues 63 (75) 77 (99)
Experts 37 (44) 91 (117)
Journals 35 (42) 95 (123)
PAMs=professionals allied to medicine.
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